Clinical trialNCT06745076RecruitingPhase 2Interventional

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

SponsorUniversity of WashingtonEnrollment125Advanced Hodgkin LymphomaClassic Hodgkin LymphomaLugano Classification Stage III Hodgkin Lymphoma AJCC v8Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Ryan Lynch, MD
Fred Hutch/University of Washington Cancer Consortium
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope
Irvine, California, United States
Azra Borogovac, MD
Recruiting
Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
Joseph Schroers-Martin, MD
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Reid Merryman, MD
Not, yet, recruiting
Washington University in St. Louis
St Louis, Missouri, United States
David Russler-Germain, MD
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Alison Moskowitz, MD
Recruiting
Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
Ryan Lynch, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Mar 2025
Primary completion: 3 Jan 2032
Completion: 3 Jan 2033
Last update posted: 9 Jul 2026
Registered enrollment: 125
Registry id: NCT06745076

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.